Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Clay Shaundra, Director. Insider active across 1 company, notably Integra Lifesciences Holdings CORP. Cumulatively, 6 disclosures have been published. Activity tracked since 14 May 2021. The latest transaction was disclosed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
6 of 6 declarations
Shaundra Clay serves as a Board Member at Integra Lifesciences Holdings Corp. She brings expertise in the medical devices and health sectors. As a board member, Shaundra plays a key role in the strategic direction of the company, ensuring regulatory compliance and innovation. Her experience is valuable in guiding strategic decisions.